| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/29/1991 | US4988679 Triglycerides, polyglyceryl esters, lecithin and alginates to form time release carriers for drugs |
| 01/29/1991 | US4988512 Nasal pharmaceutical compositions |
| 01/29/1991 | US4988506 Polysiloxane-grafted copolymer non-pressure sensitive topical binder composition and method of coating therewith |
| 01/29/1991 | US4988496 Metal radionuclide chelating compounds for improved chelation kinetics |
| 01/29/1991 | US4988456 Process for producing W/O/W type multiple emulsion for medicines |
| 01/29/1991 | CA1279575C Thiazide diuretics for antihypertension without diuresis |
| 01/29/1991 | CA1279574C Process for lubricating water-soluble vitamin powders |
| 01/28/1991 | WO1991001750A1 Lipid a analog/immunogenic carrier conjugates and the use thereof as vaccines |
| 01/28/1991 | CA2064194A1 Lipid a analog/immunogenic carrier conjugates and the use thereof as vaccines |
| 01/28/1991 | CA2021808A1 Pharmaceutical composition for oral administration containing nac |
| 01/27/1991 | CA2021872A1 Topical spironolactone composition |
| 01/26/1991 | WO1991001145A1 Pokeweed antiviral protein - monoclonal antibody conjugates |
| 01/24/1991 | WO1991000746A1 Transdermal administration of lisuride |
| 01/24/1991 | WO1990014881A3 Chelating agents for attaching metal ions to proteins |
| 01/23/1991 | EP0409690A1 Skinproducts with cosmetic and/or therapeutic effects |
| 01/23/1991 | EP0409527A2 Cis-diamineplatinum complexes with methanediphosphonate and substituted methanediphosphonate ligands as antitumor agents |
| 01/23/1991 | EP0409490A1 Method of treatment |
| 01/23/1991 | EP0409432A2 Confectionery delivery system |
| 01/23/1991 | EP0409383A2 Estradiol compositions and methods for topical applications |
| 01/23/1991 | EP0409279A2 Troche composition |
| 01/23/1991 | EP0408731A1 Crosslinked hyaluronate gels, their use and method for producing them |
| 01/23/1991 | EP0408558A1 Hydrophilic polyurethanes prepared from mixed oxyalkylene glycols |
| 01/23/1991 | CN1048712A Polymer base blend compositions containing destructurized starch |
| 01/23/1991 | CN1048659A Process for preparing hydrogel preparation and dry gel preparation |
| 01/23/1991 | CN1048656A Process for preparing polyisoprenyl compound having high content for soft capsules |
| 01/22/1991 | US4987241 Polyaluminum dialkyl phosphate, oil gelling agent comprising the same, and composition for external application comprising the same |
| 01/22/1991 | US4987169 Method of preparing silicon compositions |
| 01/22/1991 | US4987031 Mixture of gelatin and polypeptide to prevent insolubilization of former |
| 01/22/1991 | CA2020840A1 Troche composition |
| 01/22/1991 | CA1279261C Orally administerable sustained release pharmaceutical formulations |
| 01/21/1991 | CA2021544A1 Confectionery delivery system for actives |
| 01/18/1991 | CA2017739A1 Cis-diamineplatinum complexes with methanediphosphonate and substituted methanediphosphonate ligands as antitumor agents |
| 01/16/1991 | EP0408502A2 Polymer base blend compositions containing destructurized starch |
| 01/16/1991 | EP0408501A2 Polymer base blend compositions containing destructurized starch |
| 01/16/1991 | EP0408496A2 Solid dosage form for pharmaceutical substances |
| 01/16/1991 | EP0408370A2 Stable tretinoin emulsified cream formulations |
| 01/16/1991 | EP0408273A1 Fosinopril tablet formulations |
| 01/16/1991 | EP0408174A1 Antiseptic composition containing hexahydro-5-pyrimidinamine compounds |
| 01/16/1991 | EP0408157A1 Acid-cleavable compound |
| 01/16/1991 | EP0408069A2 Emulsions comprising aminopolysaccharides |
| 01/16/1991 | EP0408019A2 Pharmaceutical active derivative delivery systems |
| 01/16/1991 | EP0408017A2 Delivery systems for quaternary and related compounds |
| 01/16/1991 | EP0407815A2 Polyprenyl compound composition for soft capsules |
| 01/16/1991 | EP0407804A1 Water soluble pharmaceutical composition containing metallocen-complex |
| 01/16/1991 | EP0407617A1 Process for the preparation of a biocompatible polyester |
| 01/16/1991 | EP0407543A1 Mammalian gap-43 compositions and methods of use |
| 01/16/1991 | EP0407399A1 Immunosupression with anti-pan t-cell immunotoxin compositions |
| 01/16/1991 | EP0400015A4 Hydrophilic polyurethanes of improved strength |
| 01/16/1991 | CN1048496A Aqueous liquid composition for external use |
| 01/15/1991 | WO1991001146A1 Cytokine and hormone carriers for conjugate vaccines |
| 01/15/1991 | US4985541 Novel cytotoxic protein |
| 01/15/1991 | US4985455 External preparations free of discoloration |
| 01/15/1991 | US4985425 Dissolved composition of [benzo-1,2,4-thiadiazine]-1,1-dioxide |
| 01/15/1991 | US4985404 Prolonged release of biologically active polypeptides |
| 01/15/1991 | US4985252 Improved efficacy for drugs |
| 01/15/1991 | US4985245 tPA-containing medical composition |
| 01/15/1991 | US4985242 Polypeptide, Quaternary Ammonium Compound, Cellulose Ether |
| 01/15/1991 | US4985173 Process for producing a W/O/W type multiple emulsion for medicines, cosmetics, etc. |
| 01/15/1991 | CA2063271A1 Cytokine and hormone carriers for conjugate vaccines |
| 01/15/1991 | CA1279012C Process for preparing immunogenic complexes and pharmaceutical composition containing these complexes |
| 01/13/1991 | CA2020966A1 Polymeric salt delivery systems |
| 01/13/1991 | CA2020964A1 Pharmaceutical active derivative delivery systems |
| 01/13/1991 | CA2020963A1 Delivery systems for quaternary and related compounds |
| 01/13/1991 | CA2020891A1 Antiseptic compositions containing hexahydro-5-pyrimidinamine compounds and an amphoteric surfactant and methods for preparing same |
| 01/13/1991 | CA2020802A1 Solid dosage form for pharmaceutically active drugs |
| 01/12/1991 | CA2020818A1 Emulsions comprising aminopolysaccharides |
| 01/12/1991 | CA2020404A1 Polymer base blend compositions containing destructurized starch |
| 01/12/1991 | CA2020403A1 Polymer base blend compositions containing destructurized starch |
| 01/11/1991 | CA2020261A1 Polyprenyl compound composition for soft capsules |
| 01/10/1991 | WO1991000360A1 Bispecific reagents for aids therapy |
| 01/10/1991 | WO1991000359A1 Particle-mediated transformation of animal somatic cells |
| 01/10/1991 | WO1991000295A1 Novel antibodies reactive with human carcinomas |
| 01/10/1991 | WO1991000289A2 Targeted liposomes and methods for liposome-protein coupling |
| 01/10/1991 | WO1991000112A1 Antibody-lactate oxidase conjugates |
| 01/10/1991 | WO1991000111A1 Targetting agents |
| 01/10/1991 | WO1991000110A1 Fluorocarbon emulsions having saturated phospholipid emulsifiers |
| 01/10/1991 | WO1991000108A1 Antibody-oxidase conjugates with non-systemic substrates |
| 01/10/1991 | WO1991000107A1 Vaccines and vectors with liquid active principles containing an oil which can be metabolised |
| 01/10/1991 | WO1991000106A1 Injectable multi-phase emulsions |
| 01/10/1991 | WO1991000100A2 Toxin uses |
| 01/10/1991 | WO1991000094A1 A new papaverine injection system |
| 01/10/1991 | WO1990012874A3 Cysteine added variants of polypeptides and chemical modifications thereof |
| 01/10/1991 | CA2062795A1 Bispecific reagents for aids therapy |
| 01/09/1991 | EP0407148A2 Angiographic adjuvant |
| 01/09/1991 | EP0407122A1 Novel modified PF4 compositions and methods of use |
| 01/09/1991 | EP0407000A2 Aqueous preparation of an pyrido[1,2-a] pyrimidine compound |
| 01/09/1991 | EP0406856A2 Stabilized FGF composition and production thereof |
| 01/09/1991 | EP0406811A2 Novel clathrate compounds and a drug comprising them |
| 01/09/1991 | EP0406791A2 Aqueous liquid composition for external use |
| 01/09/1991 | EP0406623A2 Polyaspartic acid derivatives as a coating for pharmaceutical forms and foodstuffs |
| 01/09/1991 | EP0406367A1 Scavenger receptor protein and antibody thereto |
| 01/09/1991 | EP0406364A1 Veterinary composition and a process for the preparation thereof |
| 01/09/1991 | EP0406307A1 Water soluble ibuprofen compositions and methods of making them |
| 01/09/1991 | EP0401215A4 Hydrophilic carboxy polyurethanes |
| 01/09/1991 | CN1048322A Stable, cosmetically acceptable topical gel formulation and method of treatment for ache |
| 01/08/1991 | WO1991000739A1 Stable motilin preparation |
| 01/08/1991 | WO1991000738A1 Aqueous solution of motilin |
| 01/08/1991 | WO1991000728A1 Benzophenanthridine alkaloids for topical acne treatment |
| 01/08/1991 | US4983745 Depolymerization of racemic polylactic acid with tin |
| 01/08/1991 | US4983636 Composition and method of treating selected malignant conditions |